The Role of Teplizumab in Newly Diagnosed Type 1 Diabetes

IF 3.7 3区医学 Q2 ENDOCRINOLOGY & METABOLISM Endocrine Practice Pub Date : 2024-10-01 DOI:10.1016/j.eprac.2024.06.014

引用次数: 0

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

致编辑的信内分泌实践特普利珠单抗在新诊断的 1 型糖尿病中的作用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Endocrine Practice ENDOCRINOLOGY & METABOLISM-

CiteScore

7.60

自引率

2.40%

发文量

546

审稿时长

41 days

期刊介绍： Endocrine Practice (ISSN: 1530-891X), a peer-reviewed journal published twelve times a year, is the official journal of the American Association of Clinical Endocrinologists (AACE). The primary mission of Endocrine Practice is to enhance the health care of patients with endocrine diseases through continuing education of practicing endocrinologists.

期刊最新文献

Comprehensive Analysis of Mitotane-Related Adverse Events Using the FDA Adverse Event Reporting System. The role of active brown adipose tissue in patients with pheochromocytoma or paraganglioma (PPGL). Comparative Effectiveness of Abaloparatide and Teriparatide in Women 50 Years of Age and Older: Update of a Real-world Retrospective Analysis. Glucose Disorders in Patients with Pheochromocytoma/Paraganglioma: Profile and influence effects in a large cohort with 705 patients. Loss of Follow-up for Thyroid Nodules in Patients Living in Poverty.